Pharma Stocks
-
The Quiet Pharma Tech Power Move Wall Street Is Sleeping On
Everyone’s chasing meme stocks while Certara Inc quietly powers the drug brands you actually use. Is CERT the next under-the-radar…
Read More » -
Mankind Pharma Limited’s (NSE:MANKIND) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
It is hard to get excited after looking at Mankind Pharma’s (NSE:MANKIND) recent performance, when its stock has declined 11%…
Read More » -
Is Amylyx Pharmaceuticals’ (AMLX) New GLP-1 Rare Disease Bet Expanding or Diluting Its Core Strategy?
Earlier in January 2026, Amylyx Pharmaceuticals announced it had selected AMX0318, a long-acting GLP-1 receptor antagonist discovered with Gubra A/S,…
Read More » -
Assessing IDEAYA Biosciences (IDYA) Valuation After Bullish Analyst Reports And Big Pharma Partnerships
IDEAYA Biosciences (IDYA) is back in focus after a cluster of upbeat analyst reports highlighted its precision oncology pipeline and…
Read More » -
Is Jazz (JAZZ) Quietly Recasting Its Oncology Strategy Through HER2 Partnerships And Voucher Monetization?
In recent days, Boehringer Ingelheim announced a clinical collaboration with Jazz Pharmaceuticals to test a combination of zongertinib and Jazz’s…
Read More » -
Takeda Pharmaceutical (TSE:4502) Valuation Check After Recent Share Price Momentum
Why Takeda Pharmaceutical Stock Is On Investors’ Radar Takeda Pharmaceutical (TSE:4502) has recently drawn attention after a strong run in…
Read More » -
Defensive Pharma Giant Tests Investors’ Patience As Shares Slip Despite Solid Pipel
GSK plc (ADR) has drifted lower over the past week, even as the British drugmaker pushes deeper into vaccines, HIV…
Read More » -
Is This ‘Boring’ Pharma Stock About To Blow Up?
Gilead Sciences just pulled a quiet power move on Wall Street. Is this sleepy pharma giant a low-key gold mine…
Read More » -
A Look At Crinetics Pharmaceuticals (CRNX) Valuation After Goldman Sachs Upgrade And Palsonify Atumelnant Progress
Crinetics Pharmaceuticals (CRNX) has been in focus after a Goldman Sachs analyst upgrade that followed positive Phase 2 data for…
Read More » -
60 Degree Pharma To Implement 1-for-4 Reverse Stock Split To Regain Nasdaq Compliance
(RTTNews) – 60 Degree Pharmaceuticals, Inc. (SXTP) is preparing to consolidate its shares in a one-for-four (1:4) reverse stock split,…
Read More »